About Formulary - Formulary

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

About Formulary
Formulary is a monthly clinical journal for members of pharmacy and therapeutics (P & T) committees (and others charged with drug management responsibilities) at hospitals, HMOs and other managed care settings, PBM companies, and within the VA system. We publish peer-reviewed clinical articles plus drug-related clinical news, drug-related regulatory news, meeting "pearl" reports, formulary trends, and clinical experience briefs.
Our Mission
To provide timely, accurate, and practical drug-related information to assist our readers in their drug-management responsibilities—evaluating drugs for the formulary and developing policies and procedures to guide the appropriate, rational, safe, and cost-effective use of drugs.
Copyright and Permissions
No part of Formulary may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system without permission in writing from the publisher.

Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients is granted by Advanstar Communications for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr., Danvers, MA 01923, or call (978) 750-8400 for copying beyond that permitted by Sections 107 or 108 of the U.S. Copyright Law. For those not registered with the CCC, forward your permission requests to Advanstar Communications, Attn: Permissions, 24950 Country Club Blvd., Suite 200, Cleveland, OH 44070, or fax (440) 891-2740.



ADVERTISEMENT



Stay connected to Formulary
Receive web-exclusive articles, clinical news, and conference updates!

ADVERTISEMENT

Modern Medicine logoFormulary archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting FormularyJournal.com for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Click here